Early diagnosis and aggressive treatment are essential to mitigate the cascading events that lead to irreversible joint erosion in rheumatoid arthritis.
Herpes zoster was linked to an increased stroke risk in first 90 days among patients with an autoimmune disease.
The researchers estimated that only 1 in 6 patients gained a benefit from taking NSAIDs.
A thorough work-up can differentiate between primary and secondary forms, mitigating progression of a more severe underlying disease.
Multidimensional algorithms may help clinicians make a provisional diagnosis of gout.
Patients with septic arthritis with poor functional outcome who underwent ultrasonography showed decreased synovial thickness at 3 months.
Patients benefit from non-pharmacological treatment in a structured arthritis rehabilitation program.
Consultations for musculoskeletal symptoms and infections increase prior to an inflammatory arthritis diagnosis.
Multibiomarker disease activity improved relapse prediction in RA patients who are in remission.
Early and aggressive management of RA is urged by investigators.
It is critical to identify disease-modifying antirheumatic drugs for elderly patients with rheumatoid arthritis.
Researchers found that ultrasonography of selected joints can improve clinical assessment.
The use of gold therapy as an anticancer agent appears promising, as does its more common use as a DMARD.
Researchers found no serious adverse events related to treatment with cannabinoids.
Glucocorticoid therapy in patients with rheumatoid arthritis has been linked to elevated risk of diabetes.
After 8 weeks, patients with rheumatoid arthritis who took probiotics showed improvements in disease activity and metabolic health.
Nearly 12% of patients in remission from RA still experience clinically significant pain.
The biosimilar has also been approved for Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
In patients with rheumatoid arthritis, there are disparities between radiologic and goniometric measurements of joint deviation.
A number of therapeutic options exist for patients with psoriasis, including phototherapy and systemic and biologic agents.
A molecule found in green tea may block a protein that causes the symptoms of rheumatoid arthritis.
A multidisciplinary approach to diagnosing and treating enteropathic spondyloarthritis (ESpA) is the best way to ensure a patient gets comprehensive care.
RA patients treated with biologics have exhibited either clinical remission or low disease activity on follow-up visits.
Cardiovascular deaths have significantly decreased among people with rheumatoid arthritis.
Due to improved treatment options, rheumatoid arthritis mortality rates have decreased since 2000.
Updated American College of Rheumatology recommendations suggest using first-line DMARDs in combination with biologic agents and nonbiologic DMARDs to achieve therapeutic efficacy in rheumatoid arthritis treatment.
Research has shown a positive correlation between bariatric surgery-associated weight loss and decreased rheumatoid arthritis disease activity.
Patients with rheumatoid arthritis who are treated at practices with NPs and PAs exhibited lower disease activity over 2 years.
Patients with psoriasis or psoriatic arthritis who undergo bariatric surgery may see significant improvements in disease severity.
The NIH has pledged to renew research efforts into the cause and treatment of myalgic encephalomyelitis/chronic fatigue syndrome.